STIM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.986600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.588600E-01
Normal-vs-Stage2
4.852800E-01
Normal-vs-Stage3
1.887150E-01
Normal-vs-Stage4
4.037600E-01
Stage1-vs-Stage2
1.167560E-01
Stage1-vs-Stage3
7.562500E-02
Stage1-vs-Stage4
1.734770E-01
Stage2-vs-Stage3
1.769980E-01
Stage2-vs-Stage4
5.342200E-01
Stage3-vs-Stage4
4.235800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.956600E-01
Normal-vs-AfricanAmerican
6.000000E-01
Normal-vs-Asian
4.313000E-01
Caucasian-vs-AfricanAmerican
2.230400E-01
Caucasian-vs-Asian
5.062000E-01
AfricanAmerican-vs-Asian
7.148100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.001000E-01
Normal-vs-Female
4.979200E-01
Male-vs-Female
9.641200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.921400E-01
Normal-vs-Age(41-60Yrs)
5.590200E-01
Normal-vs-Age(61-80Yrs)
4.723600E-01
Normal-vs-Age(81-100Yrs)
4.882000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.602600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.230200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.576400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.555650E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.093600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.335200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.917400E-01
Normal-vs-Daily Drinker
3.840800E-01
Normal-vs-Weekly Drinker
3.922400E-01
Normal-vs-Occasional Drinker
4.950000E-01
Normal-vs-Social Drinker
5.914400E-01
Non Drinker-vs-Daily Drinker
1.023580E-01
Non Drinker-vs-Weekly Drinker
2.882800E-01
Non Drinker-vs-Occasional Drinker
9.618600E-01
Non Drinker-vs-Social Drinker
3.912800E-01
Daily Drinker-vs-Weekly Drinker
9.788400E-01
Daily Drinker-vs-Occasional Drinker
5.110500E-02
Daily Drinker-vs-Social Drinker
1.223600E-01
Weekly Drinker-vs-Occasional Drinker
2.262000E-01
Weekly Drinker-vs-Social Drinker
1.600000E-01
Occasional Drinker-vs-Social Drinker
3.970800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.790560E-01
Normal-vs-Grade 2
8.112200E-02
Normal-vs-Grade 3
1.655030E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.189600E-02
Grade 1-vs-Grade 3
1.376400E-01
Grade 1-vs-Grade 4
1.790560E-01
Grade 2-vs-Grade 3
8.077800E-01
Grade 2-vs-Grade 4
8.112200E-02
Grade 3-vs-Grade 4
1.655030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.478800E-01
Normal-vs-NonDiabetic
4.724800E-01
Diabetic-vs-NonDiabetic
6.475400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.055600E-01
Normal-vs-NoPancreatitis
4.701800E-01
Pancreatitis-vs-NoPancreatitis
2.347200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.055400E-01
Normal-vs-N1
4.647800E-01
N0-vs-N1
7.548500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.370800E-01
Normal-vs-TP53-NonMutant
5.204400E-01
TP53-Mutant-vs-TP53-NonMutant
4.350600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
